| Literature DB >> 32250221 |
Epole Ntungwe N1,2, Eva M Domínguez-Martín1,2, Amilcar Roberto1, Joana Tavares1, Vera M S Isca1,3, Paula Pereira1,4, Maria-João Cebola1,4, Patrícia Rijo1,3.
Abstract
Medicinal plants are a good source of novel therapeutic drugs, due to the phytochemicals present. Artemia, commonly known as brine shrimp, is a tiny halophilic invertebrate belonging to class Crustacean, which plays an important role in saline aquatic and marine eco-systems. Besides its usage in aquaculture, it is also highly valued for its application in toxicity detection and it is used in areas such as Ecology, Physiology, Ecotoxicology, Aquaculture and Genetics. Furthermore, Artemia based lethality assay (brine shrimp lethality assay, BSLA) is rapid, convenient and low cost. Presently, brine shrimp lethality assays are enormously employed in research and applied toxicology. It has been used in the study of natural products as a preliminary toxicity assay to screen a large number of extracts and compounds for drug discovery in medicinal plants. The aim of this review paper is to collect, organize, select and discuss the existing knowledge about the different uses of Artemia salina as a bench-top bioassay for the discovery and purification of bioactive natural products. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Artemia; alternative model; brine shrimp; correlation; general toxicity; natural products; screening
Mesh:
Year: 2020 PMID: 32250221 DOI: 10.2174/1381612826666200406083035
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116